RNAC · Company research
Cartesian Therapeutics, Inc. Common Stock (RNAC): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
15records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| APP,RCAT,CCC,OPTU,INOD,MRKR,RNAC,OKLO,ARDX,AJG | Stock Prices | Quote Comparison - Yahoo! Finance Canada | APP,RCAT,CCC,OPTU,INOD,MRKR,RNAC,OKLO,ARDX,AJG | Stock Prices | Quote Comparison Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 17, 2026 | neutral | 0 | 0.6 |
| The Technical Signals Behind (RNAC) That Institutions Follow - Stock Traders Daily | The Technical Signals Behind (RNAC) That Institutions Follow Stock Traders Daily | View source ↗ | Stock Traders Daily | Oct 17, 2026 | neutral | 0 | 0.6 |
| Cartesian Therapeutics Inc. (NASDAQ: RNAC) Share Price, RNAC Stock News, RNAC Share Price & Updates - Kalkine | Cartesian Therapeutics Inc. (NASDAQ: RNAC) Share Price, RNAC Stock News, RNAC Share Price & Updates Kalkine | View source ↗ | Kalkine | Oct 9, 2026 | neutral | 0 | 0.6 |
| Understanding Momentum Shifts in (RNAC) - Stock Traders Daily | Understanding Momentum Shifts in (RNAC) Stock Traders Daily | View source ↗ | Stock Traders Daily | Oct 6, 2026 | neutral | 0 | 0.6 |
| Four new hires received the right to buy 121,900 shares at Cartesian Therapeutics - Stock Titan | Four new hires received the right to buy 121,900 shares at Cartesian Therapeutics Stock Titan | View source ↗ | Stock Titan | Oct 2, 2026 | neutral | 0 | 0.6 |
| Analysts Offer Insights on Healthcare Companies: Cartesian Therapeutics (RNAC), Immix Biopharma (IMMX) and Surgery Partners (SGRY) - The Globe and Mail | Analysts Offer Insights on Healthcare Companies: Cartesian Therapeutics (RNAC), Immix Biopharma (IMMX) and Surgery Partners (SGRY) The Globe and Mail | View source ↗ | The Globe and Mail | Oct 1, 2026 | neutral | 0 | 0.6 |
| Five patients averaged a 6.6-point symptom-score reduction from baseline 12 months after retreatment - Stock Titan | Five patients averaged a 6.6-point symptom-score reduction from baseline 12 months after retreatment Stock Titan | View source ↗ | Stock Titan | Sep 29, 2026 | neutral | 0 | 0.6 |
| Three new hires can buy 59,700 Cartesian shares at $9.27 - Stock Titan | Three new hires can buy 59,700 Cartesian shares at $9.27 Stock Titan | View source ↗ | Stock Titan | Sep 8, 2026 | neutral | 0 | 0.6 |
| RNAC Forecast — Price Target — Prediction for 2027 - TradingView | RNAC Forecast — Price Target — Prediction for 2027 TradingView | View source ↗ | TradingView | Jun 26, 2026 | neutral | 0 | 0.6 |
| $RNAC stock is up 12% today. Here's what we see in our data. - Quiver Quantitative | $RNAC stock is up 12% today. Here's what we see in our data. Quiver Quantitative | View source ↗ | Quiver Quantitative | Jun 17, 2026 | neutral | 0 | 0.6 |
| Cartesian Therapeutics (RNAC) Shares Surge 30% on Licensing Agre - GuruFocus | Cartesian Therapeutics (RNAC) Shares Surge 30% on Licensing Agre GuruFocus | View source ↗ | GuruFocus | Jun 9, 2026 | neutral | 0 | 0.6 |
| We're Keeping An Eye On Cartesian Therapeutics' (NASDAQ:RNAC) Cash Burn Rate - Yahoo Finance | We're Keeping An Eye On Cartesian Therapeutics' (NASDAQ:RNAC) Cash Burn Rate Yahoo Finance | View source ↗ | Yahoo Finance | May 17, 2026 | neutral | 0 | 0.6 |
| We Think Cartesian Therapeutics (NASDAQ:RNAC) Needs To Drive Business Growth Carefully - Simply Wall Street | We Think Cartesian Therapeutics (NASDAQ:RNAC) Needs To Drive Business Growth Carefully Simply Wall Street | View source ↗ | Simply Wall Street | May 17, 2026 | neutral | 0 | 0.6 |
| Cartesian Therapeutics: A Phase 3 mRNA CAR-T Bet - Seeking Alpha | Cartesian Therapeutics: A Phase 3 mRNA CAR-T Bet Seeking Alpha | View source ↗ | Seeking Alpha | Apr 23, 2026 | neutral | 0 | 0.6 |
| $RNAC stock is up 7% today. Here's what we see in our data. - Quiver Quantitative | $RNAC stock is up 7% today. Here's what we see in our data. Quiver Quantitative | View source ↗ | Quiver Quantitative | Mar 9, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.